Cytokinetics Inc (CYTK)
62.11
-1.92
(-3.00%)
USD |
NASDAQ |
May 10, 16:00
62.00
-0.11
(-0.18%)
After-Hours: 20:00
Cytokinetics Cash from Operations (TTM): -414.33M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -414.33M |
September 30, 2023 | -438.49M |
June 30, 2023 | -426.32M |
March 31, 2023 | -394.99M |
December 31, 2022 | -299.52M |
September 30, 2022 | -246.06M |
June 30, 2022 | -200.79M |
March 31, 2022 | -139.81M |
December 31, 2021 | -142.52M |
September 30, 2021 | -45.64M |
June 30, 2021 | 7.502M |
March 31, 2021 | 9.559M |
December 31, 2020 | 8.943M |
September 30, 2020 | -62.26M |
June 30, 2020 | -96.90M |
March 31, 2020 | -94.14M |
December 31, 2019 | -90.91M |
September 30, 2019 | -84.18M |
June 30, 2019 | -96.15M |
March 31, 2019 | -98.32M |
December 31, 2018 | -101.22M |
September 30, 2018 | -112.96M |
June 30, 2018 | -106.21M |
March 31, 2018 | -110.62M |
December 31, 2017 | -101.76M |
Date | Value |
---|---|
September 30, 2017 | 0.141M |
June 30, 2017 | 13.50M |
March 31, 2017 | 33.54M |
December 31, 2016 | 36.98M |
September 30, 2016 | -50.79M |
June 30, 2016 | -49.01M |
March 31, 2016 | -46.98M |
December 31, 2015 | 4.883M |
September 30, 2015 | 6.695M |
June 30, 2015 | 7.527M |
March 31, 2015 | 7.338M |
December 31, 2014 | -44.84M |
September 30, 2014 | -49.14M |
June 30, 2014 | -29.32M |
March 31, 2014 | -13.32M |
December 31, 2013 | -7.718M |
September 30, 2013 | -2.413M |
June 30, 2013 | -21.60M |
March 31, 2013 | -36.92M |
December 31, 2012 | -33.44M |
September 30, 2012 | -37.26M |
June 30, 2012 | -37.64M |
March 31, 2012 | -41.45M |
December 31, 2011 | -45.60M |
September 30, 2011 | -43.74M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-438.49M
Minimum
Sep 2023
9.559M
Maximum
Mar 2021
-170.89M
Average
-96.90M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
Amgen Inc | 8.096B |
Johnson & Johnson | 23.19B |
Eli Lilly and Co | 3.676B |
Viking Therapeutics Inc | -54.87M |
Madrigal Pharmaceuticals Inc | -389.32M |